Cancer patients ineligible for trials receive immune checkpoint inhibitors at greater rates than trial eligible ones despite no survival benefit.
A new coalition of health organizations hopes to improve patient care using clinical research evidence in real time.
PAID MESSAGE Decentralized clinical trials (DCTs) are becoming one of the most dynamic ways to conduct clinical research. The ability for research sites to deploy remote trials elevates opportunities easily […]
Researchers say they have identified the attributes of a successful real-world evidence study that contribute to an accelerated or full drug approval.
With robust community engagement, equitable inclusion in vaccine trials can make a powerful impact on the health of underrepresented communities.